Alison Scrimgeour

Director - Biometrics at Silence Therapeutics - East Palo Alto, CA, US

Alison Scrimgeour's Colleagues at Silence Therapeutics
Nadia Grishin

Interim Finance Manager

Contact Nadia Grishin

Curtis Rambaran

Vice President Clinical Sciences

Contact Curtis Rambaran

Tiffani White

Associate Director of Regulatory Affairs

Contact Tiffani White

Bill Abernethy

Vice President, Global Market Development

Contact Bill Abernethy

Elaine Anderson

Director, Alliance Management

Contact Elaine Anderson

Phillip Carter

Vice President, New Product Development - Cardiovascular / Hematology

Contact Phillip Carter

View All Alison Scrimgeour's Colleagues
Alison Scrimgeour's Contact Details
HQ
650-855-9696
Location
Milton Keynes, England, United Kingdom
Company
Silence Therapeutics
Alison Scrimgeour's Company Details
Silence Therapeutics logo, Silence Therapeutics contact details

Silence Therapeutics

East Palo Alto, CA, US • 100 - 249 Employees
BioTech/Drugs

Silence Therapeutics is developing a new generation of medicines by harnessing the body's natural mechanism of RNA interference, or RNAi, to inhibit the expression of specific target genes thought to play a role in the pathology of diseases with significant unmet medical need. Silence's proprietary messenger RNAi GOLD™ Platform can be used to create siRNAs that precisely target and silence disease-associated genes in the liver, which represents a substantial opportunity. Silence's wholly owned product candidates include SLN360 designed to address the high and prevalent unmet medical need in reducing cardiovascular risk in people born with high levels of lipoprotein(a) and SLN124 designed to address iron loading anemias. Silence also maintains ongoing research and development collaborations with AstraZeneca, Mallinckrodt Pharmaceuticals, and Takeda, among others. For more information, please visit https://www.silence-therapeutics.com/.To view our social media guidelines, please visit: https://silence-therapeutics.com/social-media-guidelines

Biotechnology RNA Interference RNAi siRNA B2B BioTech/Drugs Commercial Physical Research
Details about Silence Therapeutics
Frequently Asked Questions about Alison Scrimgeour
Alison Scrimgeour currently works for Silence Therapeutics.
Alison Scrimgeour's role at Silence Therapeutics is Director - Biometrics.
Alison Scrimgeour's email address is ***@silence-therapeutics.com. To view Alison Scrimgeour's full email address, please signup to ConnectPlex.
Alison Scrimgeour works in the BioTech/Drugs industry.
Alison Scrimgeour's colleagues at Silence Therapeutics are Nadia Grishin, Curtis Rambaran, Tiffani White, Bill Abernethy, Rhonda Hellums, Elaine Anderson, Phillip Carter and others.
Alison Scrimgeour's phone number is 650-855-9696
See more information about Alison Scrimgeour